A Trial of Anti-TNF Chimeric Monoclonal Antibody (cA2) in Korean Patients With Active Rheumatoid Arthritis Despite Methorexate (Extension Part)(Study P05645)(COMPLETED)
Clinical trial NCT00732875 · COMPLETED
Trial details
- NCT number
- NCT00732875
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-08-01
- Primary completion
- 2008-05-01
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.